- ►annals.org MB Rothberg, C Celestin, LD Fiore, E Lawler, … - Annals of internal medicine, 2005 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: After the acute coronary syndrome, adding warfarin to standard ... Cited by 74 - Related articles - BL Direct - All 4 versions
K Buresly, MJ Eisenberg, X Zhang, L Pilote - Archives of Internal Medicine, 2005 - archinte.highwire.org Background Combinations of aspirin with thienopyridine derivatives (clopidogrel
bisulfate or ticlopidine hydrochloride) and/or warfarin sodium are increasingly
being used in various cardiac conditions. However, little is known about ... Cited by 101 - Related articles - All 8 versions
- ►nih.gov RJ Larson, ES Fisher - Journal of General Internal Medicine, 2004 - Springer BACKGROUND AND OBJECTIVE: Clinicians frequently face the decision of whether to
continue aspirin when starting patients on warfarin. We performed a
meta-analysis to characterize the tradeoffs involved in this common ... Cited by 22 - Related articles - BL Direct - All 12 versions
P Lechat, H Lardoux, A Mallet, P Sanchez, G … - CEREBROVASCULAR DISEASES-BASEL-, 2001 - content.karger.com Background: A combination of low-dose aspirin with anticoagulants may provide
better protection against thromboembolic events compared to anticoagulants alone
in high-risk patients with atrial fibrillation. Objective: Evaluation of ... Cited by 51 - Related articles - BL Direct - All 6 versions
F Dentali, JD Douketis, W Lim, M Crowther - Archives of Internal Medicine, 2007 - Am Med Assoc Background For patients receiving oral anticoagulant (OAC) therapy, deciding
whether to add aspirin to their treatment is a common clinical scenario with no
clear guidelines to aid practice. We performed a systematic review and meta- ... Cited by 49 - Related articles - BL Direct - All 6 versions
R Mehran, GD Dangas - JACC: Cardiovascular Interventions, 2008 - Elsevier Corresponding Author Contact Information Reprint requests and correspondence:
Dr. Roxana Mehran, Columbia University Medical Center, 55 East 59th Street, 6th
Floor, New York, New York 10022-1112. low asterisk Editorials published in ... Cited by 5 - Related articles - All 13 versions
- ►ahajournals.org MA Brouwer, PJPC van den Bergh, WRM … - Circulation, 2002 - Am Heart Assoc Methods and Results— At coronary angiography <48 hours after fibrinolytic
therapy, 308 patients receiving aspirin and intravenous heparin had a patent
infarct-related artery (Thrombolysis In Myocardial Infarction [TIMI] grade ... Cited by 104 - Related articles - BL Direct - All 12 versions
A Rubboli, M Milandri, C Castelvetri, B Cosmi - Cardiology-Basel, 2005 - content.karger.com The combination of oral anticoagulation (OAC) and aspirin was the antithrombotic
treatment initially adopted after coronary stenting (PCI-S). Although dual
antiplatelet therapy with aspirin and a thienopyridine subsequently proved ... Cited by 38 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org ASH Cheng, JB Selvanayagam, M Jerosch- … - JACC Interventions, 2008 - interventions.onlinejacc.org Objectives: We sought to investigate temporal changes in contractility and
hyperemic and resting myocardial blood flow (MBF) in dependent and remote
myocardium after percutaneous coronary intervention (PCI) of chronic total ... Cited by 7 - Related articles - All 13 versions